Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Employer
- ICN2
- Harvard University
- Institut Català de Nanociència i Nanotecnologia
- Radboud University
- University of Antwerp
- Amsterdam UMC
- Anacker Lab
- ETH Zurich
- ETH Zürich
- Institute for Bioengineering of Catalonia (IBEC)
- Institute for bioengineering of Catalonia, IBEC
- MOHAMMED VI POLYTECHNIC UNIVERSITY
- Macquarie University
- Missouri University of Science and Technology
- NIST
- Northeastern University
- SciLifeLab
- Technical University of Darmstadt •
- Texas A&M AgriLife
- The University of Queensland
- UCL;
- University of Bath
- University of Birmingham
- University of Denver
- University of Glasgow
- University of Graz
- University of Manchester
- Wageningen University & Research
- 18 more »
- « less
-
Field
-
for three consecutive periods (2014-2018 and 2018-2022 and 2023-2026). ICN2 comprises 20 Research Groups, 7 Technical Development and Support Units and Facilities, and 2 Research Platforms, covering different
-
for three consecutive periods (2014-2018 and 2018-2022 and 2023-2026). ICN2 comprises 20 Research Groups, 7 Technical Development and Support Units and Facilities, and 2 Research Platforms, covering different
-
biosensors of metabolism, and we study the dynamics of metabolism in mouse brain using both ex vivo and in vivo imaging methods. We also work to learn the role of altered metabolism in preventing epileptic
-
for three consecutive periods (2014-2018 and 2018-2022 and 2023-2026). ICN2 comprises 20 Research Groups, 7 Technical Development and Support Units and Facilities, and 2 Research Platforms, covering different
-
and its potential as a therapeutic target. Your work will include: Developing cell-based bioluminescent and fluorescent biosensor assays to detect GPCR signalling events in different cellular models
-
individual differences in stress vulnerability and resilience with a specific focus on how early life adversity shapes hippocampal and corticolimbic circuit function to influence fear behavior and cognitive
-
for three consecutive periods (2014-2018 and 2018-2022 and 2023-2026). ICN2 comprises 20 Research Groups, 7 Technical Development and Support Units and Facilities, and 2 Research Platforms, covering different
-
for three consecutive periods (2014-2018 and 2018-2022 and 2023-2026). ICN2 comprises 20 Research Groups, 7 Technical Development and Support Units and Facilities, and 2 Research Platforms, covering different
-
of different chemical and biological wearable/implantable/point-of-care sensors using these materials for the high precision detection of biomarkers and physiological parameters, such as proteins, DNA, antigen
-
act on the human body and communication behavior — for example, voice-controlled assistive technology, mobile health, virtual reality, socially assistive robotics, wearable biosensors, or digital twins